In the first quarter of fiscal 2025, HOLX is expected to have benefited from the strength of its core franchises.

With Hologic, Inc. HOLX gearing up to release its fiscal 2025 first-quarter financial results on Feb. 5 after the market ...

Shares of Hologic Inc. HOLX shed 1.35% to $71.77 Tuesday, on what proved to be an all-around favorable trading session for ...

This was the stock's second consecutive day of gains.

Hologic (HOLX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...

The U.S. Food and Drug Administration has sent a warning letter to Marlborough, Mass.-based medical technology company ...

Hologic is down approximately 20% from recent highs and continues to grow organically and via a series of 'bolt-on' ...

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store. Hologic stopped manufacturing the device after ...

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $71.02 which represents a slight increase of $0.32 or 0.45% from the prior close of $70.7. The stock opened at $70.45 and touched a low ...

Hologic Inc (HOLX) stock saw a modest uptick, ending the day at $70.37 which represents a slight increase of $0.64 or 0.92% from the prior close of $69.73. The stock opened at $69.98 and touched a low ...

Investment analysts at Leerink Partnrs lowered their Q2 2025 EPS estimates for shares of Hologic in a research note issued on ...

The Hologic Women’s Health Index’s 2023 data found a decrease in testing for any cancer among women — a first in the survey’s ...